Andrew J. Sheldon

Andrew J. Sheldon discloses dealings in Immunovaccine Inc. to SEDI. We count 12 filings; the first trade dates from 14 April 2016 and the latest from 22 March 2018.

The open-market record is one-sided, with 6 purchases worth €62k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 option exercise. In 2018 alone, the filings show 4 purchases and no sales.

Half of the purchases are above €9,720 and half below. None of the 6 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The latest filing, published on 22 March 2018, reports an open-market purchase of €622 in Immunovaccine Inc. The median gap between a trade and its publication by SEDI is 1 day. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.